350 results
Penicillin is the most common drug allergy reported. However, most people are not actually allergic to penicillin. In this article, DynaMed Allergy Specialist Dr. Maureen Bauer answers common questions about penicillin allergy delabeling.
EBSCO Information Services’ Clinical Decisions announces plans to leverage generative artificial intelligence technology within its point-of-care resources. Read the editorial principles behind their measured approach.
It’s not magic, but the magnitude of benefit for psilocybin compared to other available treatments for major depressive disorder plus its relative lack of adverse effects suggests that this treatment might be about ready for prime time.
While COVID-19 took much of the world’s attention in 2020, clinical research in other areas continued. Here are the top DynaMed® topics and important new research in those areas.
Every few months, another drug for potential use in treating dermatologic disorders seems to enter the pipeline. Patient choice is great, but unknown comparative efficacy, conflicts of interest, and prohibitive costs complicate this choice.
Dynamic Health Editor-in-Chief Diane Hanson, RN, BSN, MM, FNAP, shares insights on leadership from her recent appearance on MissingLogic's "The TRU Leader" podcast. Read about the interview and check out the episode.
DynaMedex makes the grade in a new study evaluating this point-of-care (POC) resource to answer real-world disease-related clinical questions.
Nearly all patients with MEN1 develop tumors, so screening is an important aspect of managing disease progression. Find tips for developing a balanced and thoughtful approach to screening in the latest blog article from the editors at DynaMed.
KidsCareEverywhere (KCE) empowers clinicians in Vietnam and Cambodia with access to DynaMed and promotes project sustainability through local DynaMed Champions. Read about KCE’s campaign to bring evidence-based medical information to clinicians worldwide.
In the final installment of this four-part series on statins for primary prevention of cardiovascular disease, we reflect on what we’ve learned throughout the series and distill it into simple, actionable takeaways.